Activity of single agent vinorelbine in pretreated non-Hodgkin's lymphoma

Annals of Oncology

Volumn 7, Issue 9, 1996, Pages 970-972

  Balzarotti, M ^a   Santoro, A ^a   Tondini, C ^a   Fornier, M ^a   Bonadonna, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

non Hodgkin's lymphoma; salvage therapy; vinorelbine

Indexed keywords

NAVELBINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MALE; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0030468310     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010802     Document Type: Article

References (9)

1. Velasquez WS, Cabanillas F, Salvador P et al. Effective salvage therapy for lymphoma with cisplatin in combination with highdose Ara-C and dexamethazone (DHAP). Blood 1988; 71: 117-22.
2. Velasquez WS, McLaughin P, Tucker S et al. ESHAP an effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow up study. J Clin Oncol 1994; 12: 1169-76.
3. Rodriguez MA, Cabanillas FC, Hagemeister FB et al. A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas. Ann Oncol 1995; 6: 609-11.
4. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540-5.
5. Weber BL, Vogel C. Jones S et al. Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer. J Clin Oncol 1995; 13: 2722-30.
6. Le Chevalier T, Brisgand D, Douillard JY et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell-lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 1994; 12: 200-34.
7. Conroy T, Etienne PL, Adenis A et al. Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. J Clin Oncol 1996; 14: 164-70.
8. Devizzi L, Santoro A, Bonfante V et al. Vinorelbine: An active drug for the management of patients with heavily pretreated Hodgkin's disease. Ann Oncol 1994 5: 817-20.
9. Eghbali H. Phase study of vinorelbine (navelbine) in previously treated Hodgkin's disease and non-Hodgkin's lymphoma. In Solal Celigny P (ed): Navelbine Update and New Trends. Paris, France: John Libbey Eurotext Ltd 1991; 253-60.